Insights on the Nerve Repair and Regeneration Devices Global Market to 2026 – Featuring Abbott Laboratories, LivaNova and Stryker Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Nerve Repair and Regeneration Devices – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Nerve Repair and Regeneration Devices estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2026, growing at a CAGR of 10% over the analysis period.

Neurostimulation & Neuromodulation Devices, one of the segments analyzed in the report, is projected to grow at a 9.7% CAGR to reach US$10.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biomaterials segment is readjusted to a revised 11.7% CAGR for the next 7-year period. This segment currently accounts for a 13.8% share of the global Nerve Repair and Regeneration Devices market.

The neurostimulation and neuromodulation devices segment growth will be fueled by rising incidence of peripheral nerve injuries, development of technologically advanced products and favorable reimbursement scenario. Within the segment, internal neurostimulation and neuromodulation devices category is being driven due to the devices’ ability to lower occurrence of post-surgical complications and reducing duration of hospitalization. Biomaterials segment is expected to witness high growth, driven by broadening application range, increased availability of government funding for innovations, and development of advanced products.

Select Competitors (Total 61 Featured) –

• Abbott Laboratories, Inc.
• AxoGen, Inc.
• Boston Scientific Corporation
• Integra LifeSciences Corporation
• LivaNova, PLC
• Medtronic plc
• NeuroPace, Inc.
• Nevro Corporation.
• Orthomed S.A.S.
• Polyganics B.V.
• Stryker Corporation
• Synapse Biomedical Inc.
• Synovis Micro Companies Alliance, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

• Impact of Covid-19 and a Looming Global Recession
• 2020 Marked as a Year of Disruption & Transformation
• World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
• Global Nerve Repair & Regeneration Market Buckles under COVID-19 Strain
• Covid-19 Patients in Prone Position Suffering Nerve Damage Bodes Well for Market Growth
• Nerve Repair and Regeneration Market Set for a Robust Growth
• Neurostimulation & Neuromodulation Devices Hold Commanding Slot in Nerve Repair & Regeneration Market
• Biomaterials to Exhibit Rapid Growth
• Nerve Repair and Regeneration Market by Application
• US and Europe Dominate the Market
• Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
• Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• High Incidence of Neurological Disorders: A Key Market Driver
• Annual Incidence of Adult-Onset Neurologic Disorders in the US
• Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
• Increasing Cases of Peripheral Nerve Injuries Drive the Nerve Repair and Regeneration Market
• Growing Number of Vehicular Accidents Drive the Peripheral Nerve injuries Repair Market
• Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders
• Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
• Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
• Global Alzheimer’s Prevalence by Age Group
• Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
• Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
• Select Available Deep Brain Stimulation Devices Available in the Market
• Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism
• Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
• Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
• Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy
• Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
• Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
• Recent Developments in Spinal Cord Injury Treatment
• Biomaterials (Nerve Conduits and Nerve Wraps) to Witness Rapid Growth
• New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies
• Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/9c6zr3.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900